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Noninvasive augmentation of microvessel number
in patients with peripheral vascular disease
Anthony J. Clover, BMedSci, BM BS, Mark J. McCarthy, MB ChB, PhD, Kaniz Hodgkinson, RN, Peter
R. F. Bell, MD, and Nicholas P. J. Brindle, PhD, Leicester, United Kingdom
Objective: Therapeutic angiogenesis has great potential for the treatment of ischemic diseases. One possible route for
noninvasive induction of microvessels has recently been suggested by the finding that subcontractile electrical stimulation
induces increased vascularization in animals. The present study tests the ability of such stimulation to augment
microvessel number in patients with peripheral vascular disease.
Design of study: Overall, 36 patients were randomly assigned to control (n 12) and treatment (n 24) groups. Patients
in the treatment group received localized subcontractile electrical stimulation on the feet of their ischemic limbs for three
60-minute periods each day over a 6-week period. Microvessel density was determined by capillary microscopy before
treatment, at 3 and 6 weeks during treatment, and 4 weeks after completion. Transcutaneous oxygen tension was also
determined at this site.
Results: Microvessel density determined by capillary microscopy was significantly increased (1.25-fold, P < .005) during
and after treatment in patients receiving electrical stimulation. Transcutaneous oxygen tension was similarly increased in
the treated patients (1.24-fold, P < .05). No changes were observed in these parameters in untreated patients examined
in parallel.
Conclusion: Localized subcontractile electrical stimulation can increase microvessel density and tissue perfusion in patients
with peripheral vascular disease. (J Vasc Surg 2003;38:1309-12.)
Tissue ischemia is a major cause of mortality and mor-
bidity. At present, the treatment options available for pa-
tients with peripheral vascular disease are a combination of
angioplasty and reconstructive surgery. In addition, there
have been promising advances in development of potential
therapeutic strategies aimed at inducing new vessel growth
by administration of exogenous growth factors, either in
the form of peptides or via gene therapy.1,2 Inducing vessel
growth by stimulating endogenous release of angiogenic
factors might avoid some of the potential complications of
growth factor administration, such as supraphysiologic lev-
els of growth factor and unwanted effects of angiogenesis at
sites distinct from the target tissue.3,4 Recently, a noninva-
sive method was described for inducing increased microves-
sel density in a rat hind limb ischemia model by using
low-voltage subcontractile electrical stimulation.5 In addi-
tion, intermittent stimulation of both animal and human
cells in culture was shown to increase vascular endothelial
growth factor (VEGF) release. Translation of these effects
to patients with ischemic disease would provide an attrac-
tive adjunct to existing treatments.
The aim of this study was to determine whether sub-
contractile electrical stimulation could induce increased
microvessel density in patients with peripheral vascular
disease. By localizing stimulation over relatively small areas
on the ischemic limb and directly visualizing microvessels
by capillary microscopy, we provide proof of concept that
subcontractile stimulation can promote increased mi-
crovessel density in these patients.
MATERIAL AND METHODS
Patient selection. The study was approved by the
local ethics committee. Patients with a stable claudication
distance for 12 months were recruited from outpatient
clinics, and informed consent was obtained. Overall, 36
patients with moderate peripheral vascular disease as de-
fined by the TransAtlantic Inter-Society Consensus Docu-
ment6 were randomized into treatment (n  24) and
control (n 12) groups (Table). Patients were randomized
by selection of envelopes; this was a block randomization
due to limitations on the number of transcutaneous elec-
trical stimulators. Patients were assessed for nailfold mi-
crovessel density and transcutaneous oxygen tension on
presentation and after a 6-week treatment period. Treat-
ment patients were also assessed 3 weeks into the study and
1 month after completion of treatment. The assessment at
1-month posttreatment in the treated group was to deter-
mine whether the changes in capillary number were main-
tained beyond the treatment period. As the control group
did not demonstrate any changes during the treatment
period, there were no changes to examine 1 month after the
treatment period in these patients; therefore, control pa-
tients were not assessed at this time point. All investigations
were carried out in a temperature-controlled examination
room, maintained between 22°C and 24°C. The same
practitioner carried out all investigations. Patients were
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given a 15-minute acclimatization period prior to
investigations.
Subcontractile electrical stimulation. Localized
stimulation at 10 mA, 1.0 V at a frequency of 8 Hz was
delivered with an Elpha 4 Conti transcutaneous electrical
stimulator (ERP Group Ltd, Laval, Quebec, Canada).
Electrodes were applied to a 5  5-cm area on the first
metatarsal joint of the affected limb. Stimulation was ap-
plied for three equally spaced 1-hour periods each day for
the 6-week treatment period. The control group received
no intervention between weeks 0 and 10. Patients were not
stimulated for the 12- to 18-hour period before assessment.
Treatment was self-administered by the patients after initial
education from the trial nurse. Patients were provided with
access contact numbers to help with any problems with the
treatment. Compliance and treatment regimes were as-
sessed at each consultation.
Capillary microscopy. Capillary microscopy allows
for visualization of nailfold capillaries. Capillary microscopy
was performed essentially as described by Ubbink et al,7
with a Leitz Wetzlar microscope (Leica Microsystems AG,
Wetzlar, Germany). Images were obtained at 300 mag-
nification and recorded on videotape for off-line analysis.
Patients were in a sitting position, and measurements were
taken immediately upon release of arterial occlusion.7 The
area selected for measurement was at the nailfold directly
adjacent to the area treated with subcontractile stimulation.
Mean microvessel density was calculated from measure-
ments of five 1-mm2 fields for each patient and validated by
two independent assessors. Both interobserver and intraob-
server variation were calculated in order to validate deter-
mination of capillary density. Intraobserver variation was
calculated by counting 85 fields twice on separate occasions
from 17 individual patients blinded to the initial result,
with a correlation coefficient of .96. Interobserver variation
was calculated for the two assessors who counted capillary
density in 135 fields from 27 patients, with a correlation
coefficient of .95 between assessors.
Transcutaneous oxygen tension. Measurement of
transcutaneous oxygen tension enables assessment of skin
oxygen supply from superficial vessels. Measurements were
performed with a Radiometer TCM 30 transcutaneous
oxygen monitor (Radiometer Medical A/S, Brønshøj,
Denmark) at an electrode temperature of 44 °C and were
taken at the treatment sites during reactive hyperemia after
a 3-minute arterial occlusion.7
Statistical analysis. Results are calculated relative to
the pretreatment basal value for each patient. Results are
expressed as a mean SEM. Unpaired t tests were used. A
value of P  .05 in two-tailed tests was regarded as
significant.
RESULTS
Capillary microscopy. Patients received subcontrac-
tile electrical stimulation for three 1-hour periods per day
for a 6-week treatment period. Capillary microscopy was
performed at the adjacent nailfold at presentation, and after
3 and 6 weeks of treatment and 1 month after completion
of treatment. Capillary density at presentation was 27.2 
6.0 and 27.3  4.1 capillaries/field (mean  SD) for
treatment and control groups, respectively. Representative
capillary images pretreatment and posttreatment are shown
for two treated and one control patient in Fig 1, A. This was
quantified for each patient at each assessment, and relative
change in microvessel number was calculated by compari-
son with the baseline pretreatment value for each patient.
There were no changes in microvessel density between
baseline and 6 weeks in the control group. In contrast, a
significant increase in microvessel density was noted above
pretreatment microvessel density at 3 and 6 weeks of treat-
ment and 4 weeks posttreatment in the treated group.
Microvessel density in the treatment group showed a max-
imal stimulation at 6 weeks of 25% above pretreatment
values and was sustained for the 4 weeks after treatment
ceased (Fig 1, B).
Transcutaneous oxygen. To gain insight into the ef-
fects of the stimulation on local perfusion, patients were
assessed for transcutaneous oxygen tension in the treat-
ment area on the foot. Again, relative changes in transcu-
taneous oxygen tension were calculated for each patient by
comparison to the baseline pretreatment value for each
patient. There was no change in oxygen tension between
baseline and 6 weeks in the control group. However, there
was a trend toward an increase in transcutaneous oxygen
tension at each time point in the treated patients. This
reached statistical significance after 10 weeks, with maximal
levels of 1.24-fold those of pretreatment values (Fig 2).
DISCUSSION
This study provides proof of concept that subcontrac-
tile electrical stimulation can increase microvessel density in
human subjects. Furthermore, this increase is demon-
strated in a group of patients with peripheral vascular
disease. These data extend the previous animal study,5 and
they suggest a possible noninvasive route for augmenting
microvessel density in patients with peripheral vascular
disease. As suggested previously,3 there may be significant
advantages in devising strategies for enhancing microvessel
density that do not require administration of exogenous
factors. These advantages could include a more physiologic
vascularization due to lower levels of angiogenic cytokines.
Furthermore, localized stimulation might be expected to
induce vascularization at a locoregional level, without large
Characteristics of study patients
Treatment Control
Number 24 12
Age (y) 71.9 (47-86) 72 (47-81)
Sex (M/F) 19/5 9/3
Diabetes mellitus 7 4
Active smokers (Ex) 3 (20) 1 (10)
APBI 0.56 (0.35-0.79) 0.63 (0.31-0.76)
Values are n unless otherwise indicated.
ABPI, Ankle:brachial pressure index, mean (range).
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systemic changes in angiogenic growth factor concentra-
tions.
Subcontractile stimulation may lead to increased mi-
crovessel density by means of a number of routes. Studies
with cultured animal and human cells have shown that
subcontractile electrical stimulation activates production of
VEGF.5 This raises the possibility that VEGF could con-
tribute to the increased vessel density seen in these patients,
although further experiments will be required to test this.
The effects of electrical stimulation on growth factor ex-
pression is not confined to VEGF; for example, IGF-II is
induced in osteosarcoma cells in response to low-amplitude
stimulation.8 Formation of new vessels, as well as arterio-
genesis, involves a complex interplay of factors, including
VEGF, angiopoietins, and extracellular matrix cues.9 It is
possible that electrical stimulation may induce production
of a number of factors that could contribute to augmenta-
tion of microvessel number by stimulating new vessel for-
mation. Pulsed electromagnetic fields have also been shown
to directly increase proliferation of cultured endothelial
cells and their organization into vessel-like structures,10
suggesting potential additional mechanisms.
The present study was focused on determining whether
subcontractile stimulation can augment microvessel num-
ber in patients with peripheral vascular disease. To test this,
we used small treatment areas and directly examined mi-
crovessel number, confining analyses to superficial mi-
crovessels. The data do show that such stimulation can
induce an increased microvessel density. Transcutaneous
oxygen tension was also increased in treated patients, al-
though due to the variance between patients, this did not
reach statistical significance at 3 and 6 weeks. An attractive
feature of low-voltage transcutaneous electrical stimulation
is that it is painless and well tolerated by patients, with no
Fig 1. Increased microvessel density induced by subcontractile stimulation. (A) Representative images from capillary
microscopy show appearance of microvessels pretreatment and post-treatment (6-week time point) for two individuals
treated with subcontractile stimulation and one control subject. (B) Microvessel density adjacent to the stimulation site
is significantly increased at each time point during and after treatment. Data are presented as means  SEM for 12
control patients assessed at 6 weeks and 24 treated patients assessed at the times shown (**, P  .005). Data are
presented as microvessel density relative to the pretreatment value for each patient.
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known side effects. If the increased microvessel numbers
seen with localized stimulation can be extended by the use
of larger treatment areas and optimization of stimulation
parameters for the relevant ischemic areas, such an ap-
proach may provide clinical benefit.
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Fig 2. Increased transcutaneous oxygen induced by subcontrac-
tile stimulation. Transcutaneous oxygen levels are also significantly
increased at the stimulation site 4 weeks posttreatment. Data are
presented as means  SEM for 12 control patients assessed at 6
weeks and 24 treated patients assessed at the times shown (*, P 
.05). Data are presented as microvessel density relative to the
pretreatment value for each patient.
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